Landelle Caroline, Birgand Gabriel, Price James R, Mutters Nico T, Morgan Daniel J, Lucet Jean-Christophe, Kerneis Solen, Zingg Walter
University of Grenoble Alpes, CNRS, UMR 5525, Grenoble INP, CHU Grenoble Alpes, Infection Prevention and Control Unit, 38000 Grenoble, France.
National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at Imperial College London, London, UK.
Antimicrob Steward Healthc Epidemiol. 2023 Jul 26;3(1):e128. doi: 10.1017/ash.2023.200. eCollection 2023.
Three years after the beginning of the COVID-19 pandemic, better knowledge on the transmission of respiratory viral infections (RVI) including the contribution of asymptomatic infections encouraged most healthcare centers to implement universal masking. The evolution of the SARS-CoV-2 epidemiology and improved immunization of the population call for the infection and prevention control community to revisit the masking strategy in healthcare. In this narrative review, we consider factors for de-escalating universal masking in healthcare centers, addressing compliance with the mask policy, local epidemiology, the level of protection provided by medical face masks, the consequences of absenteeism and presenteeism, as well as logistics, costs, and ecological impact. Most current national and international guidelines for mask use are based on the level of community transmission of SARS-CoV-2. Actions are now required to refine future recommendations, such as establishing a list of the most relevant RVI to consider, implement reliable local RVI surveillance, and define thresholds for activating masking strategies. Considering the epidemiological context (measured via sentinel networks or wastewater analysis), and, if not available, considering a time period (winter season) may guide to three gradual levels of masking: (i) standard and transmission-based precautions and respiratory etiquette, (ii) systematic face mask wearing when in direct contact with patients, and (iii) universal masking. Cost-effectiveness analysis of the different strategies is warranted in the coming years. Masking is just one element to be considered along with other preventive measures such as staff and patient immunization, and efficient ventilation.
在新冠疫情开始三年后,人们对包括无症状感染的贡献在内的呼吸道病毒感染(RVI)传播有了更深入的了解,这促使大多数医疗中心实施普遍佩戴口罩的措施。SARS-CoV-2流行病学的演变以及人群免疫接种的改善,要求感染预防与控制领域重新审视医疗环境中的口罩策略。在这篇叙述性综述中,我们考虑了医疗中心降低普遍佩戴口罩措施的因素,包括对口罩政策的遵守情况、当地流行病学、医用口罩提供的防护水平、缺勤和出勤的后果,以及物流、成本和生态影响。目前大多数国家和国际口罩使用指南是基于SARS-CoV-2的社区传播水平制定的。现在需要采取行动完善未来的建议,比如列出需要考虑的最相关的RVI清单、实施可靠的当地RVI监测,以及确定启动口罩策略的阈值。考虑到流行病学背景(通过哨点网络或废水分析来衡量),如果没有相关数据,则考虑某个时间段(冬季),这可能会指导逐步采取三个级别的口罩措施:(i)标准和基于传播的预防措施以及呼吸道礼仪,(ii)与患者直接接触时系统佩戴口罩,以及(iii)普遍佩戴口罩。未来几年有必要对不同策略进行成本效益分析。佩戴口罩只是需要与其他预防措施(如工作人员和患者免疫接种以及高效通风)一起考虑的一个因素。